MARÍA DOLORES
SÁNCHEZ DE LA NIETA GARCÍA
Profesora asociada de Ciencias de la Salud
University of Washington
Seattle, Estados UnidosPublications en collaboration avec des chercheurs de University of Washington (2)
2023
-
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
The Lancet, Vol. 402, Núm. 10417, pp. 2077-2090
-
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
The Lancet, Vol. 401, Núm. 10388, pp. 1584-1594